Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors ,
Multivalency as a Chemical Organization and Action Principle, Angew. Chem. Int. Ed, vol.37, issue.20, pp.14-17, 1998. ,
Dimeric Zanamivir Conjugates with Various Linking Groups Are Potent, Long-Lasting Inhibitors of Influenza Neuraminidase Including H5N1 Avian Influenza, J. Med. Chem, issue.8, pp.2964-2971, 2005. ,
Potent and LongActing Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a OnceWeekly Dosing Regimen, Antimicrob. Agents Chemother, vol.48, issue.12, pp.4542-4549, 2004. ,
Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features, Bioorg. Med. Chem. Lett, vol.258, issue.6, pp.199-202, 1983. ,
Emerging Trends in Enzyme Inhibition by Multivalent Nanoconstructs, Org. Biomol. Chem, issue.39, pp.9894-9906, 2015. ,
Influencing Receptor?Ligand Binding Mechanisms with Multivalent Ligand Architecture, J. Am. Chem. Soc, vol.124, issue.50, pp.14922-14933, 2002. ,
, Tetravalent Glycocyclopeptide with Nanomolar Affinity to Wheat Germ Agglutinin. Org. Biomol. Chem, issue.41, pp.7113-7122, 2013.
A Metal-Free Synthetic Approach to Peptide-Based Iminosugar Clusters as Novel Multivalent Glycosidase Inhibitors, RSC Adv, vol.6, issue.3, pp.2210-2216, 2016. ,
Glycopeptide Dendrimers as Pseudomonas Aeruginosa Biofilm Inhibitors, Multivalent Glycoconjugate Syntheses and Applications Using Aromatic Scaffolds, vol.42, pp.173-190, 2009. ,
Applications of Nanoparticles in Biology, Adv. Mater, vol.20, issue.22, pp.4225-4241, 2008. ,
Glycopolymer Probes of Signal Transduction, Chem. Soc. Rev, vol.42, issue.10, pp.4476-4491, 2013. ,
Polymer Therapeutics: Concepts and Applications, Angew. Chem. Int. Ed, vol.45, issue.8, pp.1198-1215, 2006. ,
Calixarenes: From Biomimetic Receptors to Multivalent Ligands for Biomolecular Recognition, Their Synthesis and Biological Applications, vol.14, pp.5933-5941, 2006. ,
DNA as a Platform to Program Assemblies with Emerging Functions in Chemical Biology, Glycoclusters on Oligonucleotide and PNA Scaffolds: Synthesis and Applications, vol.36, pp.4557-4573, 2007. ,
4782-4787. (30) Caminade, A.-M.; Majoral, J.-P. Positively Charged Phosphorus Dendrimers. An Overview of Their Properties, Proc. Natl. Acad. Sci, vol.30, issue.3, pp.4055-4066, 2002. ,
Anhydrase Inhibitor Coated Gold Nanoparticles Selectively Inhibit the Tumor-Associated Isoform IX over the Cytosolic Isozymes I and II, J. Am. Chem. Soc, vol.7, issue.1, pp.16130-16131, 2008. ,
Inhibition of HIV Fusion with Multivalent Gold Nanoparticles, J. Am. Chem. Soc, vol.130, issue.22, pp.6896-6897, 2008. ,
DOI : 10.1021/ja710321g
URL : http://europepmc.org/articles/pmc2916654?pdf=render
Oxime Ligation on the Surface of Mesoporous Silica Nanoparticles, Org. Lett, vol.17, issue.9, pp.2146-2149, 2015. ,
DOI : 10.1021/acs.orglett.5b00740
Ultrasmall c(RGDyK)-Coated Fe3O4 Nanoparticles and Their Specific Targeting to Integrin ?v?3Rich Tumor Cells, J. Am. Chem. Soc, vol.130, issue.24, pp.7542-7543, 2008. ,
DOI : 10.1021/ja802003h
URL : http://europepmc.org/articles/pmc2542944?pdf=render
In Vivo TumorTargeted Fluorescence Imaging Using Near-Infrared Non-Cadmium Quantum Dots, Bioconjug. Chem, vol.21, issue.4, pp.604-609, 2010. ,
DOI : 10.1021/bc900323v
URL : http://europepmc.org/articles/pmc3617504?pdf=render
) Imahori, H. Giant Multiporphyrin Arrays as Artificial Light-Harvesting Antennas, Photosynthetic Antenna and Reaction Center Models, vol.31, pp.807-815, 1999. ,
A Two-Stage Poly(Ethylenimine)-Mediated Cytotoxicity: Implications for Gene Transfer/Therapy, Mol. Ther, vol.11, issue.6, pp.990-995 ,
DOI : 10.1016/j.ymthe.2005.02.010
URL : https://doi.org/10.1016/j.ymthe.2005.02.010
Efficient Synthesis and Photodynamic Activity of Porphyrin-Saccharide Conjugates: Targeting and Incapacitating Cancer Cells, J. R. Soc. Interface, vol.3, issue.7, pp.41529-41542, 2004. ,
Cyclodextrin Drug Carrier Systems, Chem. Rev, vol.98, issue.5, pp.2045-2076, 1998. ,
DOI : 10.1021/cr970025p
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation, Trends Biochem. Sci, vol.86, issue.2, pp.280-285, 1995. ,
Protein Design: On the Threshold of Functional Properties, Pept. Sci, vol.47, issue.1, pp.63-73, 1998. ,
Solution Structure of Regioselectively Addressable Functionalized Templates: An NMR and Restrained Molecular Dynamics Investigation, J. A. ?-Hairpin Peptidomimetics: Design, Structures and Biological Activities. Acc. Chem. Res, vol.39, issue.3, pp.1278-1288, 1996. ,
DOI : 10.1002/(sici)1097-0282(199609)39:3<297::aid-bip3>3.0.co;2-j
Recent Applications of Thiol-ene Coupling as a Click Process for Glycoconjugation, Adv. Synth. Catal, vol.2012, issue.2, pp.1655-1685, 2015. ,
A Dynamic Combinatorial Approach for Identifying Side Groups That Stabilize DNA-Templated Supramolecular SelfAssemblies, Int. J. Mol. Sci, vol.2015, issue.2, pp.3609-3625 ,
DOI : 10.3390/ijms16023609
URL : http://www.mdpi.com/1422-0067/16/2/3609/pdf
Dynamic Combinatorial Chemistry, Angew. Chem, vol.106, issue.9, pp.7633-7636, 2006. ,
The Alpha Effect. A Review, Int. J. Chem. Kinet, vol.1973, issue.1, pp.1-26 ,
The Mechanism of the Oxidative Deamination and Decarboxylation of Serine and Threonine by Periodate in Acid Medium, Angew. Chem. Int. Ed, vol.54, issue.35, pp.2349-2353, 1959. ,
Topological Effects and Binding Modes Operating with Multivalent Iminosugar-Based Glycoclusters and Mannosidases, J. Am. Chem. Soc, vol.51, issue.25, pp.18427-18435, 2013. ,
CyclodextrinBased Iminosugar Click Clusters: The First Examples of Multivalent Pharmacological Chaperones for the Treatment of Lysosomal Storage Disorders, Angew. Chem, vol.2012, issue.33, pp.13825-13831, 2010. ,
A Systematic Investigation of Iminosugar Click Clusters as Pharmacological Chaperones for the Treatment of Gaucher Disease, ChemBioChem, vol.15, issue.2, pp.309-319, 2014. ,
Polymeric Iminosugars Improve the Activity of Carbohydrate-Processing Enzymes, Bioconjug. Chem, vol.26, issue.4, pp.766-772, 2015. ,
DOI : 10.1021/acs.bioconjchem.5b00081
Carbonic Anhydrases: From Biomedical Applications of the Inhibitors and Activators to Biotechnological Use for CO2 Capture, J. Enzyme Inhib. Med. Chem, vol.100, issue.3, pp.325-332, 1933. ,
Thylakoid Luminal ?-Carbonic Anhydrase Critical for Growth and Photosynthesis in the Marine Diatom Phaeodactylum Tricornutum, Proc. Natl. Acad. Sci, vol.113, pp.9828-9833, 2016. ,
DOI : 10.1073/pnas.1603112113
URL : http://www.pnas.org/content/113/35/9828.full.pdf
Discovery of a New Family of Carbonic Anhydrases in the Malaria Pathogen Plasmodium Falciparum-The ?-Carbonic Anhydrases, Bioorg. Med. Chem. Lett, vol.7, issue.18, pp.825-833, 2007. ,
Anhydrase: Evolution of the Zinc Binding Site by Nature and by Design, Acc. Chem. Res, vol.29, issue.7, pp.331-339, 1996. ,
Carbonic Anhydrase Activators: The First X-Ray Crystallographic Study of an Adduct of Isoform I, Bioorg. Med. Chem. Lett, issue.19, pp.5152-5156, 2006. ,
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?, J. Med. Chem, vol.45, issue.4, pp.4421-4468, 2002. ,
Crystal Structure of the Catalytic Domain of the Tumor-Associated Human Carbonic Anhydrase IX, Proc. Natl. Acad. Sci, vol.106, pp.667-702, 2004. ,
Carbonic Anhydrase Inhibitors: XRay Crystallographic Structure of the Adduct of Human Isozyme II with a BisSulfonamide-two Heads Are Better than One?, Bioorg. Med. Chem. Lett, vol.13, issue.16, pp.2759-2763, 2003. ,
Two-Prong Inhibitors for Human Carbonic Anhydrase II, J. Am. Chem. Soc, vol.126, issue.41, pp.13206-13207, 2004. ,
DOI : 10.1021/ja047271k
Protein Surface-Assisted Enhancement in the Binding Affinity of an Inhibitor for Recombinant Human Carbonic Anhydrase-II, J. Am. Chem. Soc, vol.126, issue.35, pp.10875-10883, 2004. ,
Spacer-Based Selectivity in the Binding of "Two-Prong" Ligands to Recombinant Human Carbonic Anhydrase I, Biochemistry (Mosc.), vol.44, issue.9, pp.3211-3224, 2005. ,
Anhydrase Inhibitors. Comparison of Aliphatic Sulfamate/BisSulfamate Adducts with Isozymes II and IX as a Platform for Designing Tight-Binding, More Isoform-Selective Inhibitors, J. Med. Chem, vol.52, issue.19, pp.5990-5998, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00460022
Development of Potent Carbonic Anhydrase Inhibitors Incorporating Both Sulfonamide and Sulfamide Groups, J. Med. Chem, vol.2012, issue.15, pp.6776-6783 ,
A Bivalent Small Molecule-Drug Conjugate Directed against Carbonic Anhydrase IX Can Elicit Complete Tumour Regression in Mice, J. Am. Chem. Soc, vol.2012, issue.1, pp.3640-3644 ,
A SmallMolecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors, Angew. Chem. Int. Ed, vol.53, issue.16, pp.4231-4235, 2014. ,
PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas, J. Med. Chem, issue.10, pp.5077-5088, 2016. ,
DOI : 10.1021/acs.jmedchem.6b00492
Anhydrase Activators: Gold Nanoparticles Coated with Derivatized Histamine, Histidine, and Carnosine Show Enhanced Activatory Effects on Several Mammalian Isoforms, Carbonic Anhydrase Inhibitors and Activators and Their Use in Therapy. Expert Opin. Ther. Pat, vol.54, issue.5, pp.345-360, 2006. ,
DOI : 10.1021/jm101284a
URL : https://hal.archives-ouvertes.fr/hal-00676350
Two-Site Binding of Phenol in the Active Site of Human Carbonic Anhydrase II: Structural Implications for Substrate Association, J. Am. Chem. Soc, vol.116, issue.8, pp.3659-3660, 1994. ,
Anhydrase Inhibitors: Interactions of Phenols with the 12 Catalytically Active Mammalian Isoforms (CA IXIV), Bioorg. Med. Chem. Lett, vol.18, issue.5, pp.5511-5522, 2008. ,
DOI : 10.1016/j.bmcl.2008.01.077
URL : https://flore.unifi.it/bitstream/2158/369929/1/1-s2.0-S0960894X08000954-main.pdf
Sulfocoumarins (1,2-Benzoxathiine-2,2-Dioxides): A Class of Potent and Isoform-Selective Inhibitors of Tumor-Associated Carbonic Anhydrases, J. Med. Chem, vol.56, issue.1, pp.462-473, 2013. ,
The CoumarinBinding Site in Carbonic Anhydrase Accommodates Structurally Diverse Inhibitors: The Antiepileptic Lacosamide As an Example and Lead Molecule for Novel Classes of Carbonic Anhydrase Inhibitors, J. Med. Chem, issue.2, pp.850-854, 2010. ,
Novel Coumarins and Benzocoumarins Acting as Isoform-Selective Inhibitors against the Tumor-Associated Carbonic Anhydrase IX, J. Enzyme Inhib. Med. Chem, vol.54, issue.24, pp.292-296, 2011. ,
5-and 6-Membered (Thio)Lactones Are Prodrug Type Carbonic Anhydrase Inhibitors, Bioorg. Med. Chem. Lett, vol.2012, issue.1, pp.267-270 ,
DOI : 10.1016/j.bmcl.2011.11.018
) Keilin, D.; Mann, T. Carbonic anhydrase. Purification and nature of the enzyme, Chem. Commun, vol.51, issue.2, pp.8-9, 1940. ,
A Perspective on Quantitative Structure-activity Relationships and Carbonic Anhydrase Inhibitors, Expert Opin. Drug Metab. Toxicol, vol.2, issue.1, pp.113-137, 2006. ,
DOI : 10.1517/17425255.2.1.113
Crystal Structure of the C183S/C217S Mutant of Human CA VII in Complex with Acetazolamide, Bioorg. Med. Chem. Lett, issue.17, pp.5023-5026, 2010. ,
Combining the Tail and the Ring Approaches for Obtaining Potent and Isoform-Selective Carbonic Anhydrase Inhibitors: Solution and X-Ray Crystallographic Studies, Bioorg. Med. Chem, vol.22, issue.1, pp.5471-5477, 2003. ,
DOI : 10.1016/j.bmc.2013.11.016
Carbonic Anhydrase Inhibitors: Stacking with Phe131 Determines Active Site Binding Region of Inhibitors As Exemplified by the X-Ray Crystal Structure of a Membrane-Impermeant Antitumor Sulfonamide Complexed with Isozyme II, Bioorg. Med. Chem. Lett, vol.15, issue.3, pp.5721-5727, 2005. ,
Therapeutic Applications of Glycosidic Carbonic Anhydrase Inhibitors, Med. Res. Rev, vol.29, issue.3, pp.419-435, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00460025
Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata, Bioorg. Med. Chem. Lett, vol.22, pp.859-862, 2012. ,
DOI : 10.1016/j.bmcl.2011.12.033
Direct Screening of Natural Product Extracts Using Mass Spectrometry, J. Biomol. Screen, vol.13, issue.4, pp.265-275, 2008. ,
DOI : 10.1177/1087057108315739
URL : http://journals.sagepub.com/doi/pdf/10.1177/1087057108315739
Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors, J. Am. Chem. Soc, vol.131, issue.8, pp.3057-3062, 2009. ,
New Chemotypes Acting as Isozyme-Selective Carbonic Anhydrase Inhibitors with Low Affinity for the Offtarget Cytosolic Isoform II, Bioorg. Med. Chem. Lett, vol.53, issue.1, pp.2266-2273, 2010. ,
8-Disubstituted-but Not 6,7Disubstituted Coumarins Selectively Inhibit the Transmembrane, Tumor-Associated Carbonic Anhydrase Isoforms IX and XII over the Cytosolic Ones I and II in the Low Nanomolar/Subnanomolar Range, Bioorg. Med. Chem. Lett, vol.7, issue.24, pp.7255-7258, 2010. ,
Synthesis of 6-TetrazolylSubstituted Sulfocoumarins Acting as Highly Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII, Bioorg. Med. Chem, vol.22, issue.5, pp.4502-4510, 2013. ,
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors, Cancer Res, vol.71, issue.9, pp.3364-3376, 2011. ,
DOI : 10.1158/0008-5472.can-10-4261
URL : https://hal.archives-ouvertes.fr/hal-00676367
Carbonic Anhydrase Inhibitors: Synthesis and Inhibition of Cytosolic/Membrane-Associated Carbonic Anhydrase Isozymes I, II, and IX with Sulfonamides Incorporating Hydrazino Moieties, J. Med. Chem, issue.6, pp.2121-2125, 2005. ,
DOI : 10.1021/jm0494826
, Synthesis, Antimicrobial Activity and Molecular Modeling Studies of Novel Benzofuroxan Derivatives against Staphylococcus Aureus, pp.3028-3036, 2009.
DOI : 10.1016/j.bmc.2009.03.011
Preparation of Sulphonic Acids, Esters, Amides and Halides, Sulphonic Acids, Esters and their Derivatives, 1991. ,
DOI : 10.1002/0470034394.ch10
, Ltd, pp.351-399, 1991.
Identification of Organic Compounds. I. Chlorosulfonic Acid as a Reagent for the Identification of Aryl Halides, J. Am. Chem. Soc, vol.62, issue.3, pp.511-514, 1940. ,
Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors, J. Med. Chem, issue.25, pp.6367-6382, 2007. ,
, Chem. Ber, vol.91, issue.6, pp.1339-1341, 1958.
A Novel Class of Platelet Activating Factor (PAF) Antagonists. I. Synthesis and Structure-Activity Studies on PAF-Sulfonamide Isosters, Synthese Des Daphnetins. I. Berichte Dtsch. Chem. Ges, vol.40, issue.162, pp.929-936, 1992. ,
O-Mesitylenesulfonylhydroxylamine and Related Compounds-Powerful Aminating Reagents, Org. Biomol. Chem, vol.2, issue.10, pp.1-17, 1977. ,
Small Multivalent Architectures Mimicking Homotrimers of the TNF Superfamily Member CD40L: Delineating the Relationship between Structure and Effector Function, Trends Biochem. Sci, vol.129, issue.44, pp.260-265, 1988. ,
URL : https://hal.archives-ouvertes.fr/hal-00281007
) Peng, Z.-H. Solid Phase Synthesis and NMR Conformational Studies on Cyclic Decapeptide Template Molecule, Crystal Structure of a Synthetic Cyclodecapeptide for Template-Assembled Synthetic Protein Design. ChemBioChem, vol.28, issue.19, pp.432-437, 1989. ,
Template-Assembled Synthetic Proteins with Four-HelixBundle Topology. Total Chemical Synthesis and Conformational Studies, J. Am. Chem. Soc, vol.114, issue.4, pp.1463-1470, 1992. ,
Synthesis, and Properties of a Novel Cytochrome b Model, J. Am. Chem. Soc, vol.120, issue.3, pp.468-476, 1998. ,
A Novel Conformationally Constrained Parallel G Quadruplex, ChemBioChem, vol.9, issue.16, pp.2588-2591, 2008. ,
Control of Amyloid ?-Peptide Protofibril Formation by a Designed Template Assembly, Angew. Chem, vol.118, issue.17, pp.2765-2768, 2006. ,
Integrins in Cancer: Biological Implications and Therapeutic Opportunities, Nat Rev Cancer, vol.10, issue.1, pp.9-22, 2010. ,
Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and Endocytosis, Annu. Rev. Cell Dev. Biol, vol.12, issue.1, pp.5730-5739, 1996. ,
New Multifunctional Molecular Conjugate Vector for Targeting, Imaging, and Therapy of Tumors, Mol. Ther, vol.12, issue.6, pp.1168-1175, 2005. ,
Hepatocyte Targeting and Intracellular Copper Chelation by a Thiol-Containing Glycocyclopeptide, J. Am. Chem. Soc, vol.133, issue.2, pp.286-296, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01138626
Chemoselectively Template-Assembled Glycoconjugates as Mimics for Multivalent Presentation of Carbohydrates, Cyclo)Peptides. Chem. Soc. Rev, vol.45, issue.1, pp.4599-4612, 2003. ,
Dendri-RAFTs: A Second Generation of Cyclopeptide-Based Glycoclusters, Org. Biomol. Chem, vol.9, issue.6, pp.1948-1959, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01655233
Cyclic Neoglycodecapeptides: How to Increase Their Inhibitory Activity and Selectivity on Lectin/Toxin Binding to a Glycoprotein and Cells, J. Pept. Sci, vol.17, issue.6, pp.427-437, 2011. ,
High Affinity Glycodendrimers for the Lectin LecB from Pseudomonas Aeruginosa, Bioconjug. Chem, vol.24, issue.9, pp.1598-1611, 2013. ,
DOI : 10.1021/bc400239m
URL : https://hal.archives-ouvertes.fr/hal-00903491
Esterase Activities of Human Carbonic Anhydrases B and C, Cha, S. Tight-Binding Inhibitors-I. Biochem. Pharmacol, vol.24, issue.18, pp.2177-2185, 1967. ,
Carbonic Anhydrase as a Model for Biophysical and PhysicalOrganic Studies of Proteins and Protein?Ligand Binding, Chem. Rev, vol.108, issue.3, pp.946-1051, 2008. ,
DOI : 10.1021/cr050262p
URL : http://europepmc.org/articles/pmc2740730?pdf=render
Nanomedicine: Current Status and Future Prospects, FASEB J, vol.19, issue.3, pp.311-330, 2005. ,
DOI : 10.1096/fj.04-2747rev
Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized Nanoparticles, J. Am. Chem. Soc, issue.31, pp.10623-10625, 2010. ,
Applications of Nanomaterials inside Cells, Nano Today, vol.4, issue.1, pp.37-51, 2009. ,
DOI : 10.1016/j.nantod.2008.10.009
Engineered Nanoparticles for Drug Delivery in Cancer Therapy, Angew. Chem. Int. Ed, vol.53, issue.46, pp.12320-12364, 2014. ,
DOI : 10.1002/anie.201403036
Amorphous Silica Nanohybrids: Synthesis, Properties and Applications, Coord. Chem. Rev, vol.253, issue.23, pp.2998-3014, 2009. ,
DOI : 10.1016/j.ccr.2009.06.005
Review: Bioanalytical Applications of BiomoleculeFunctionalized Nanometer-Sized Doped Silica Particles, Anal. Chim. Acta, vol.647, issue.1, pp.14-30, 2009. ,
DOI : 10.1016/j.aca.2009.05.037
Optimization of Dye-Doped Silica Nanoparticles Prepared Using a Reverse Microemulsion Method, J. Colloid Interface Sci, vol.19, issue.35, pp.8336-8342, 1968. ,
Synthesis and characterization of colloidal fluorescent mesoporous silica particles, J. Colloid Interface Sci, vol.271, issue.1, pp.163-169, 2004. ,
Core/Shell Nanoparticles in Biomedical Applications, Bionanotechnology Based on Silica Nanoparticles. Med. Res. Rev, vol.209, issue.203, pp.621-638, 2004. ,
Adsorption of Human Carbonic Anhydrase II Variants to Silica Nanoparticles Occur Stepwise: Binding Is Followed by Successive Conformational Changes to a Molten-Globule-like State, J. Enzyme Inhib. Med. Chem, vol.128, issue.5, pp.759-772, 2000. ,
Synthesis of Aminocyanopyrazoles via a Multi-Component Reaction and Anti-Carbonic Anhydrase Inhibitory Activity of Their Sulfamide Derivatives against Cytosolic and Transmembrane Isoforms, Journal of Enzyme Inhibition and Medicinal Chemistry, vol.28, issue.2, pp.229-230, 2013. ,
Supramolecular Control of Oligosaccharide-Protein Interactions: Switchable and Tunable Ligands for Concanavalin A Based on ?-Cyclodextrin, Angew. Chem. Int. Ed, vol.45, issue.33, pp.5465-5468, 2006. ,
Polyhedral Oligomeric Silsesquioxane (POSS) Polymers and Copolymers: A Review, Bioconjugation on Cube-Octameric Silsesquioxanes, vol.11, pp.2224-2236, 2001. ,
DOI : 10.1002/0471712566.ch5
Cubic Polyhedral Oligomeric Silsesquioxane Based Functional Materials: Synthesis, Assembly, and Applications, Fundam. Appl. Toxicol, vol.11, issue.9, pp.996-998, 1993. ,
DOI : 10.1002/asia.201501445
Synthesis and Evaluation of Nanoglobular Macrocyclic Mn(II) Chelate Conjugates as Non-Gadolinium(III) MRI Contrast Agents, Bioconjug. Chem, vol.22, issue.5, pp.953-962, 2010. ,
DOI : 10.1021/bc100573t
URL : http://europepmc.org/articles/pmc3541050?pdf=render
Recent Developments in the Chemistry of Cubic Polyhedral Oligosilsesquioxanes, Calzaferri, G. Monosubstituted Octasilasesquioxanes. Appl. Organomet. Chem, vol.77, issue.15, pp.213-226, 1955. ,
Synthesis and Characterization of Highly Pure Azido-Functionalized Polyhedral Oligomeric Silsesquioxanes (POSS), Chem. Commun, issue.34, pp.5130-5132, 2009. ,
DOI : 10.1039/b909802j
, Towards Click Bioconjugations on Cube-Octameric Silsesquioxane Scaffolds, vol.8, pp.2212-2218, 2010.
DOI : 10.1039/b923393h
Octakis(3Azidopropyl)Octasilsesquioxane: A Versatile Nanobuilding Block for the Efficient Preparation of Highly Functionalized Cube-Octameric Polyhedral Oligosilsesquioxane Frameworks Through Click Assembly, Nonafluorobutanesulfonyl Azide: A Shelf-Stable Diazo Transfer Reagent for the Synthesis of Azides from Primary Amines, vol.489, pp.2515-2520, 1995. ,
) Fan, H.; Yang, R. Synthesis and Characterization of Polyhedral Oligomeric AzidoOctaphenylsilsesquioxane, J. Appl. Polym. Sci, vol.2012, issue.31, pp.4389-4397 ,
A Facile Synthesis of Octa(Carboxyphenyl)Silsesquioxane. Dalton Trans, pp.6919-6921, 2012. ,
DOI : 10.1039/c2dt30378g
Synthesis and Biophysical Study of Disassembling Nanohybrid Bioconjugates with a Cubic Octasilsesquioxane Core, Adv. Funct. Mater, vol.123, issue.231, pp.3191-3201, 2001. ,
Self-Assembly and Secondary Structures of Linear Polypeptides Tethered to Polyhedral Oligomeric Silsesquioxane Nanoparticles through Click Chemistry, J. Polym. Sci. Part Polym. Chem, issue.10, pp.2127-2137, 2011. ,
DOI : 10.1002/pola.24640
Hierarchical Self-Assembly and Secondary Structures of Linear Polypeptides Graft onto POSS in the Side Chain through Click Chemistry, Polym. Chem, vol.2012, issue.1, pp.162-171 ,
Glycoside and Peptide Clustering around the Octasilsesquioxane Scaffold via Photoinduced Free-Radical Thiol-ene Coupling. The Observation of a Striking Glycoside Cluster Effect, Org. Biomol. Chem, vol.2012, issue.16, pp.3269-3277 ,
URL : https://hal.archives-ouvertes.fr/hal-01654849
Copper-Free Click Chemistry for Dynamic in Vivo Imaging, Proc. Natl. Acad. Sci, vol.104, pp.16793-16797, 2007. ,
DOI : 10.1073/pnas.0707090104
URL : http://www.pnas.org/content/104/43/16793.full.pdf
Synthesis of Aromatic Functionalized Cage-Rearranged Silsesquioxanes (T8, T10, and T12) via Nucleophilic Substitution Reactions, J. Chem. Soc. Dalton Trans, vol.44, issue.7, pp.916-919, 2001. ,
High-Yield Synthesis of Amido-Functionalized Polyoctahedral Oligomeric Silsesquioxanes by Using Acyl Chlorides, J. Chem. Soc. Dalton Trans, vol.20, issue.48, pp.1491-1498, 1999. ,
DOI : 10.1002/chem.201404153
Definitions and Current Clinical, Biologic, and Molecular Aspects, JNCI J. Natl. Cancer Inst, vol.93, issue.4, pp.225-239, 2001. ,
Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, vol.3, pp.721-732, 2003. ,
DOI : 10.1038/nrc1187
Strict regulation of CAIXG250/MN by HIF-1[alpha] in clear cell renal cell carcinoma, Oncogene, vol.23, pp.5624-5631, 2004. ,
Hypoxia-Inducible Expression of Tumor-Associated Carbonic Anhydrases, Cancer Res, vol.60, issue.24, p.7075, 2000. ,
DOI : 10.1016/s0002-9440(10)64048-5
URL : http://europepmc.org/articles/pmc1850356?pdf=render
Carbonic Anhydrase IX Is Highly Expressed in Hereditary Nonpolyposis Colorectal Cancer, Cancer Epidemiol. Prev. Biomark, vol.89, issue.1, pp.1760-1766, 2003. ,
Biomarkers in Renal Cell Carcinoma, Curr. Opin. Urol, issue.5, p.19, 2009. ,
Expression of HIF-1?, CA IX, VEGF, and MMP-9 in Surgically Resected Non-Small Cell Lung Cancer, Lung Cancer, vol.49, issue.3, pp.325-335, 2005. ,
A Clinical Phase I/II Trial with the Monoclonal Antibody CG250 (RENCAREX®) and Interferon-Alpha-2a in Metastatic Renal Cell Carcinoma Patients, J. A Novel QuasiViral Agent, MaTu, Is a Two-Component System. Virology, vol.29, issue.1, pp.620-626, 1992. ,
DOI : 10.1007/s00345-010-0570-2
A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology, PLOS ONE, vol.2011, issue.12, pp.364-366, 1996. ,
DOI : 10.1371/journal.pone.0015962
URL : https://doi.org/10.1371/journal.pone.0015962
Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX, PLOS ONE, vol.2012, issue.5, p.38279 ,
Multivalent DNA Recognition by Self-Assembled Clusters: Deciphering Structural Effects by Fragments Screening and Evaluation as SiRNA Vectors, Org. Biomol. Chem, issue.36, pp.9427-9438, 2015. ,
Effective Access to Multivalent Inhibitors of Carbonic Anhydrases Promoted by Peptide Bioconjugation, Chem.-Eur. J, vol.2017, issue.28, pp.6788-6794 ,
Fluorescent Silica Nanoparticles with Multivalent Inhibitory Effects towards Carbonic Anhydrases, Chem.-Eur. J, vol.21, issue.29, pp.10306-10309, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01206436
The Carbon Dioxide Hydration Activity of Carbonic Anhydrase I. StopFlow kinetic studies on the native human isoenzymes B and C, J. Biol. Chem, issue.257, pp.2561-2573, 1971. ,
, The supernatant was then removed and the resulting solid was dried to remove traces of solvent. Yield: 97 %; 1 H NMR (400 MHz, DMSO-d 6 ) ?/ppm 8.5 (br, 1H, NH), 8 (br, O/TIS solution (95/2.5/2.5) and kept at room temperature for 3 hrs, vol.7
, After 3 hours, the crude product was then purified on semi-preparative RP-HPLC using the method A to afford a white solid after freeze-drying
D 2 O) ?/ppm 169.7 (C=O), 143.5 (C Ar ), 142.1 (C Ar ), vol.129 ,
, tert-butoxy)-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopropan-2yl)carbamate (65
, The reaction mixture was stirred at 0 °C (ice bath) for 1 hour and then warmed to room temperature and stirred for overnight. Then the mixture was concentrated and purified on silica gel chromatography using AcOEt/Cyclohexane (4/6). The expected compound 65 is obtained as yellow oil. Yield: 25 %; 1 H NMR (400 MHz, 4-methylcoumarin (1.0 g, 5.7 mmol, 1 equiv) and Boc-L-Ser(tBu)-OH (1.7 g, 6.3 mmol, 1.1 equiv) were dissolved in 10 mL of pyridine. The reaction mixture was stirred at 0?C. POCl 3 (0.8 mL, 8.55 mmol, 1.5 equiv) was added dropwise to the solution, vol.5
, Nat. Rev. Drug Discovery, vol.7, pp.168-181, 2008.
, Med. Res. Rev, vol.28, pp.445-463, 2008.
, Med. Res. Rev, vol.29, pp.419-435, 2009.
, Bioorg. Med. Chem, vol.21, pp.1419-1426, 2013.
, J. Am. Chem. Soc, vol.130, pp.16130-16131, 2008.
, J. Med. Chem, vol.54, pp.1170-1177, 2011.
, Chem. Rev, vol.113, pp.1904-2074, 2013.
, NMR Biomed, vol.27, pp.1063-1069, 2014.
, ACS Nano, vol.7, pp.8645-8657, 2013.
, Angew. Chem. Int. Ed, vol.51, pp.10472-10498, 2012.
, , vol.124, pp.10622-10650, 2012.
, Angew. Chem. Int. Ed, vol.45, pp.2348-2368, 2006.
, Angew. Chem, vol.118, pp.2408-2429, 2006.
, Chem. Soc. Rev, vol.42, pp.4515-4517, 2013.
, ChemBioChem, vol.15, pp.1239-1251, 2014.
, Chem. Eur. J, vol.20, pp.11616-11628, 2014.
, J. Am. Chem. Soc, vol.134, pp.333-345, 2012.
, Angew. Chem. Int. Ed, vol.53, pp.4231-4235, 2014.
, , vol.126, pp.4315-4320, 2014.
, J. Colloid Interface Sci, vol.271, pp.120-123, 2004.
, J. Colloid Interface Sci, vol.289, pp.125-131, 2005.
, Anal. Chim. Acta, vol.503, pp.163-169, 2004.
, Med. Res. Rev, vol.24, pp.621-638, 2004.
, Langmuir, vol.20, pp.8336-8342, 2004.
, Analyst, vol.128, pp.462-466, 2003.
, The capping of the SiÀOH group was realized in order to reduce drastically the interaction of silanol functions with the surface of the protein, and reduce the potential inhibitory activity of non-capped nanoparticles
, J. Biol. Chem, vol.246, pp.2561-2573, 1971.
, Langmuir, vol.16, pp.8470-8479, 2000.
, J. Enzyme Inhib. Med. Chem, vol.27, pp.759-772, 2012.
, J. Enzyme Inhib. Med. Chem, vol.28, pp.343-349, 2013.
, J. Enzyme Inhib. Med. Chem, vol.28, pp.229-230, 2013.
, Nat. Rev. Drug Discovery, vol.10, pp.767-777, 2011.
, Expert Opin. Ther. Pat, vol.23, pp.681-691, 2013.
, J. Enzyme Inhib. Med. Chem, vol.27, pp.138-147, 2012.
, Expert Opin. Ther. Pat, vol.23, pp.677-679, 2013.
, Angew. Chem., Int. Ed, vol.51, pp.10472-10498, 2012.
, Angew. Chem., Int. Ed, vol.37, pp.2755-2794, 1998.
, Chem. Rev, vol.102, pp.555-578, 2002.
, Special issue on Multivalent scaffolds in glycoscience: an overview, vol.42, pp.4507-4844, 2013.
, Bioconjugate Techniques, 2013.
, Chem. Soc. Rev, vol.42, pp.4657-4708, 2013.
, New J. Chem, vol.34, pp.2715-2728, 2010.
, Chem. Rev, vol.110, pp.4949-4977, 2010.
, Chem. Commun, vol.47, pp.5933-5941, 2011.
, Chem. Soc. Rev, vol.36, pp.326-334, 2007.
, J. Pept. Sci, vol.14, pp.224-240, 2008.
, , vol.7, pp.1298-1314, 2006.
, Isr. J. Chem, vol.53, pp.75-86, 2013.
, Chem. Soc. Rev, vol.42, pp.4557-4573, 2013.
, Angew. Chem., Int. Ed, vol.45, pp.1198-1215, 2006.
, Chem. Soc. Rev, vol.44, pp.3890-3899, 2015.
, Chem. Soc. Rev, vol.42, pp.4814-4822, 2013.
, Chem. Soc. Rev, vol.40, pp.173-190, 2011.
, New J. Chem, vol.33, pp.1809-1824, 2009.
, Adv. Mater, vol.20, pp.4225-4241, 2008.
, Chem. Rev, vol.113, pp.4905-4979, 2013.
, Chem.-Eur. J, vol.20, pp.34-41, 2014.
, Chem. Soc. Rev, vol.41, pp.573-586, 2012.
, Angew. Chem., Int. Ed, vol.49, pp.1540-1573, 2010.
, Angew. Chem., Int. Ed, vol.47, pp.8995-8997, 2008.
, Angew. Chem., Int. Ed, vol.45, pp.2348-2368, 2006.
, Org. Biomol. Chem, issue.11, pp.7113-7122, 2013.
, J. Am. Chem. Soc, vol.137, pp.2572-2579, 2015.
, Org. Biomol. Chem, vol.7, pp.357-363, 2009.
, J. Am. Chem. Soc, vol.135, pp.18427-18435, 2013.
, Angew. Chem., Int. Ed, vol.49, pp.5753-5756, 2010.
, ChemBioChem, vol.13, pp.661-664, 2012.
, Chem.-Eur. J, vol.17, pp.13825-13831, 2011.
, Eur. J. Org. Chem, pp.1866-1872, 2014.
, Bioconjugate Chem, vol.26, pp.766-772, 2015.
, J. Med. Chem, vol.48, pp.2964-2971, 2005.
, Antimicrob. Agents Chemother, vol.48, pp.4542-4549, 2004.
, Bioorg. Med. Chem. Lett, vol.14, pp.1589-1592, 2004.
, J. Pharm. Sci, vol.100, pp.831-835, 2011.
, Chem. Pharm. Bull, vol.51, pp.1386-1398, 2003.
, Bioorg. Med. Chem. Lett, vol.12, pp.1929-1932, 2002.
, Chem.-Eur. J, vol.21, pp.10306-10309, 2015.
, J. Am. Chem. Soc, vol.130, pp.16130-16131, 2008.
, Chem. Sci, vol.5, pp.3640-3644, 2014.
, Angew. Chem., Int. Ed, vol.53, pp.4231-4235, 2014.
, J. Am. Chem. Soc, vol.134, pp.333-345, 2012.
, Org. Biomol. Chem, vol.13, pp.6453-6457, 2015.
, J. Med. Chem, vol.58, pp.4039-4045, 2015.
, Org. Biomol. Chem, vol.13, pp.7445-7451, 2015.
, Bioorg. Med. Chem, vol.7, pp.2569-2575, 1999.
, Chem. Biol, vol.8, pp.313-327, 2001.
, Biol. Chem, vol.384, pp.1605-1611, 2003.
, J. Pept. Sci, vol.6, pp.36-46, 2000.
, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.5418-5422, 1999.
, J. Med. Chem, vol.56, pp.3367-3378, 2013.
, Eur. J. Biochem, vol.265, pp.598-605, 1999.
, Z. X. Jiang and Z. Y. Zhang, vol.5, pp.2051-2056, 2010.
, New J. Chem, vol.33, pp.148-156, 2009.
, Biochemistry, vol.54, pp.612-621, 2015.
, Bioorg. Med. Chem. Lett, vol.19, pp.1118-1121, 2009.
, New J. Chem, vol.39, pp.5050-5074, 2015.
, ChemBioChem, vol.15, pp.1239-1251, 2014.
, Chem.-Eur. J, vol.20, pp.11616-11628, 2014.
, ChemBioChem, vol.14, pp.2038-2049, 2013.
, Beilstein J. Org. Chem, vol.10, pp.1406-1412, 2014.
, Chem.-Eur. J, vol.19, pp.16791-16803, 2013.
, J. Biol. Chem, vol.284, pp.7339-7351, 2009.
, Nat. Rev. Drug Discovery, vol.7, pp.168-181, 2008.
, Chem. Rev, vol.112, pp.4421-4468, 2012.
, J. Med. Chem, vol.52, pp.5990-5998, 2009.
, J. Med. Chem, vol.55, pp.6776-6783, 2012.
, J. Med. Chem, vol.54, pp.1170-1177, 2011.
, Chem. Commun, vol.51, pp.302-305, 2015.
, Biomed Res. Int, p.453543, 2015.
, Chem.-Eur. J, vol.18, pp.641-651, 2012.
, Angew. Chem., Int. Ed, vol.53, pp.1510-1515, 2014.
, Science, vol.347, pp.779-784, 2015.
, Org. Biomol. Chem, issue.11, pp.219-232, 2013.
, Chem. Soc. Rev, vol.39, pp.2817-2826, 2010.
, Angew. Chem., Int. Ed, vol.52, pp.2915-2919, 2013.
, Angew. Chem., Int. Ed, vol.52, pp.12077-12080, 2013.
, Chem.-Eur. J, vol.20, pp.6960-6977, 2014.
, Angew. Chem., Int. Ed, vol.53, pp.9917-9921, 2014.
, Chem.-Eur. J, vol.19, pp.5259-5262, 2013.
, Proc. Natl. Acad. Sci. U. S. A, vol.110, pp.12203-12208, 2013.
, Eur. J. Org. Chem, pp.3470-3476, 2013.
, Acc. Chem. Res, vol.48, pp.1319-1331, 2015.
, ChemBioChem, vol.15, pp.1268-1273, 2014.
, Nat. Commun, vol.3, pp.1813-1817, 2011.
, Science, vol.295, pp.2418-2421, 2002.
, Langmuir, vol.29, pp.6420-6428, 2013.
, J. Am. Chem. Soc, vol.115, pp.1146-1147, 1993.
, J. Am. Chem. Soc, vol.114, pp.7303-7305, 1992.
, Chem.-Eur. J, vol.15, pp.328-332, 2009.
, Biomaterials, vol.31, pp.9117-9127, 2010.
, Angew. Chem., Int. Ed, vol.42, pp.1486-1490, 2003.
, Org. Biomol. Chem, vol.4, pp.766-769, 2006.
, Langmuir, vol.23, pp.737-746, 2007.
, Chem. Commun, pp.4700-4702, 2008.
, Mol. Pharmaceutics, vol.8, pp.416-429, 2011.
, J. Am. Chem. Soc, vol.133, 2011.
, Angew. Chem., Int. Ed, vol.53, pp.11822-11827, 2014.
, Angew. Chem., Int. Ed, vol.54, issue.35, pp.10183-10187, 2015.
, Chem.-Eur. J, vol.20, pp.14705-14714, 2014.
, Chem. Commun, vol.51, pp.2021-2024, 2015.
, Chem. Commun, vol.50, pp.3350-3352, 2014.
, Chem. Commun, vol.47, pp.12747-12753, 2011.
, Nat. Chem, vol.7, pp.241-249, 2015.
, ACS Chem. Biol, vol.6, pp.336-344, 2011.
, Chem. Soc. Rev, vol.43, pp.1899-1933, 2014.
, Topics in Current Chemistry: Constitutional Dynamic Chemistry, vol.322, pp.2211-2221, 2012.
, J. Am. Chem. Soc, vol.135, pp.9222-9239, 2013.
, Dynamic Combinatorial Chemistry in Drug Discovery, Bioorganic Chemistry, and Materials Science, 2010.
, Org. Biomol. Chem, vol.6, pp.219-226, 2008.
, Chem. Rev, vol.106, pp.3652-3711, 2006.
, Chem.-Eur. J, vol.5, pp.2455-2463, 1999.
, Angew. Chem., Int. Ed, vol.41, pp.898-952, 2002.
, Chem. Soc. Rev, vol.44, pp.2455-2488, 2015.
, Chem. Commun, vol.50, pp.5810-5825, 2014.
, Angew. Chem., Int. Ed, vol.54, pp.7924-7928, 2015.
, Chem. Commun, vol.51, pp.5436-5439, 2015.
, Org. Biomol. Chem, vol.11, pp.1679-1695, 2013.
, Angew. Chem., Int. Ed, vol.51, pp.6320-6326, 2012.
, Angew. Chem., Int. Ed, vol.50, pp.1901-1904, 2011.
, Bioconjugate Chem, vol.20, pp.1497-1502, 2009.
, PLoS One, vol.6, issue.9, pp.1044-1050, 2010.
, Bioorg. Med. Chem. Lett, vol.20, pp.2718-2721, 2010.
, J. Am. Chem. Soc, vol.130, pp.6896-6897, 2008.
, Bioconjugate Chem, vol.22, pp.1354-1365, 2011.
, Angew. Chem., Int. Ed, vol.53, pp.8037-8040, 2014.
,
, 01"22%3)4"(5,-6. ))7"#5"8)902:,-". ));8"0&'0)4<)=0>0$"(,-6. ))=?6"#3'%()@8$'51A
, /083'E"8%(5:) 1"#) '2>$%##'E%) %++%53#) G() H6'GI2G8%508"$)
31$G0J1)31%)#'2083, G+)2083'>8%)5G>'%#) ,
K%"L)2'88'2G8"$)6'(&%$)'(3G)")>G3%(3) ("(G2G8"$) G(%<) 41%) '2>8%2%(3"3'G() G+), p.51 ,
&) 1'31%$3G) $%8:'(J) G() 31%) $"(&G2) %N>8G$"3'G() G+) (%K ,
3'8%)2%31G&)31"3)%("68%#)31%)5G(#3$053'G() G+)2083'E"8%(3)#:#3%2#)+G$)31%)'(1'6'3'G()G+)5"$6G ,
,
,
53'G(<)PN'2%) ,
#055%##+088:) 0#%&) +G$) 31%) >$%> ,
, 3%#) 3%31%$%&) K'31) #08>1G("2'&%)
, ##":#) #1GK), O) '(1'6'3G$#<) 41%) %(M:2%) '(1'6'3'G(
, GE%8) 5G2>G0(&#,) 603) "8#G) $%E%"8) E"$'G0#) #3$0530$"8) %++%53#)
&%&) 6:) 31%) #5"++G8&#<) 41%) E%$#"3'8'3:) G+) 31'#) ,
, 3%)31%)%N>8G$"3'G()G+)#3$0530$%C"53'E'3:)$%8"3'G(#1'>#)+G$)E"$'G0#) 3:>%#)G+)G31%$)%(M:2%)
, 10%4+7-$%&+0( /083'E"8%(5:) %++%53#) 1"E%) 6%%() %N3%(#'E%8:) %N>8G$%&) '(
, ++'('3:) +G$) 8%53'(#) 31"3) '#) %(1"(5%&) 6:) #%E%$"8) G$&%$#) G+), G+) 2083'>8%) '(3%$"53'G(#<-S. ) TG$) %N"2>8%,) 2"(:) &'++%$%(3) 3:>%#) G+) #:(31%3'5) J8:5G580#3%$#) &'#>8":) "(
, 41%) $G8%) G+) 2083'E"8%(5:) '() %(M:2%)
33%(3'G(,) 2G#3) 8'L%8:), 6%5"0#%) %(M:2%#) ,
, 53'E%) #'3%) K1'51) #1G08&) 2"L%) 31%2), 0#0"88:) >G##%##) ") #'(J8%)
, G+)'(1'6'3G$#<)VGK%E%$,) '(3$'J0'(J) %++%53#) 1"E%) 6%%() $%5%(38:) $%>G$3%&) '() 31%) "$%"<-W. ) /083'E"8%(3) '2'(G#0J"$) 580#3%$#) K%$%) +G0(&) 3G) &'#>8":) ") J$%"3%$) >G3%(5:) 5G2>"$%&) 3G) 31%) 2G(GE"8%(3) 5G2>G0(&) 3GK"$&) 31%) '(1'6'3'G()G+)5%$3"'()J8:5G#'&"#%#<-X. )41%)2%51"('#3'5)G$'J'()G+)31'#) %++%53)'#)#3'88)0(&%$)
, 580#3%$'(J) G+) 31%) %(M:2%#) G(3G) 31%) 2083'E"8%(3) 5G2>G0(&,)
2>8:) #3"3'#3'5"8) %++%53#) 31"3) $%#083) +$G2) 31%) '(5$%"#%&) 8G5"8) ,
, #) 31%$%+G$%) #3'88) '() '3#) '(+"(5:) "(&) $%#3) G() "() %N>8G$"3G$:) ">>$G"51) 31"3) $%R0'$%#) %++%53'E%), G+) '(1'6'3G$#<) 41%) ">>8'5"3'G() G+) 2083'E"8%(5:) '() %(M:2%)
, 8#G) +G$) 2G&08"3'(J) 31%'$) #%8%53'E'3:,)%#>%5, +G$)%(M:2%#)K1'51)"$%)&'2%$#)G$)3%3$"2%$#<), vol.88
, (&) %E"80"3'G() G+) 2083'E"8%(3) '(1'6'3G$#) G+) 5"$6G('5) "(1:&$"#%#) H;O#,) Z;) X<U<S<SI) 31"3
, Y3)#1G08&)6%)2%(3'G(%&)31"3)2"(:)
, $%)2G(G2%$'5)%(M:2%#
, #G2%)G+)31%2)"$%)"8#G)&'2%$#,)G$)1'J1%$)G8'JG2%$#)H&'2%$#
, 31%
&) M'(5) 2%3"88G>$G3%'(#) '() 1'J1%$) E%$3%6$"3%#<) \:), G+ ,
, 53'E%) '#G+G$2#) +G0(&) '() 102, (&) 31%) 6'5"$6G, vol.88
(&) +80'&) +G$2"3'G(<-]. ) 7"31G8GJ'5"8) >$G5%##%#) 5"() 6%) '(&05%&) 0>G() &%$%J08"3%&) "53'E'3:) G+) 31%#%) '#G+G$2#) "(&) 2"(:) G+) 31%2) "$%) %#3"68'#1%&) '2>G$3 ,
#%#)#051)"#)J8"05G2")H1 ,
, O)YY,), p.1
, , p.1
,
, O)Y_)"(&), p.1
(& ) %>'8%>#:)H1 ,
, O)YY,), p.1
,
, >>$G"51)1"#)6%%()$%5%(38:)'2>8%2%(3%& ) '()31%), 41%)2083'E"8%(3)
, +'%8&)G+)
, +G$)'2>$GE'(J)31%)'(1'6'3G$:)"53'E'3:)603
, 3G) 5'$502E%(3) 31%) 8"5L) G+) #%8%53'E'3:) G+), vol.5
, #GM:2%#<-W. )
, OC%(5G&%&)8'6$"$'%#,)!%$'c#)J$G0>)'&%(3'+'%&)6', @#'(J), vol.9
, 3)31%)6'E"8%(5:)%++%53)G$'J'("3%#)+$G2) 6'(&'(J)3G)")#%5G(&"$:)>G8"$)#'3%), O) '(1'6'3G$#) G+) #062'5$G2G8"$) >G3%(5:) "(&) >$G>G#%&,) 6"#%&) G() 5$:#3"88GJ$">1'5)&"3
8<) 1"E%) $%E'%K%&) 31%) &'++%$%(3) 3:>%#)G+)#%5G(&"$:)'(3%$"53'G(#)31"3)5"()6%)%N>8G'3%&)6:)6', 31'#) 5G(3%N3,) F1'3%#'&%#) %3) ,
#:#3%2#)G+)1'J1%$)E"8%(5:)1"E%)6%%()%N>8G$%&)+G$) 31%) '(1'6'3'G() G+) 5"$6G, :&$"#%#<) F%) >$%E'G0#8:) 0#%&), vol.38 ,
, ) #'8'5") ("(G>"$3'58%#) 5G"3%&) K'31) 2083'>8%) 5G>'%#) HSUC S[I) G+) #08+G
, O) '(1'6'3G$#<-SW. ) 41%) $%#083#) #1GK%&) "(
G0#8:) G6#%$E%&) K'31) JG8&) ("(G>"$3'58%#-SX. I,) 603) "8#G) ,
, #>%5'+'5)2083'E"8%(5:)%++%53)"J"'(#3)31%)5:3G#G8'5, p.1
, O)Y) "(&), p.1
31%)3$"(#2%26$"(%)'#G+G$2#)1 ,
, O)Y_)"(&)1;O)
, _YY<)41%)^'(5%(3)J$G0>)&%#5$'6%&)2083'2%$'5)
, OC'(1'6'3G$#)1"E'(J)
, #)N"(31"3%)HWC]) '(1'6'3G$#I-S]. ) G$) 5G02"$'() HSU) '(1'6'3G$#I<-S`. ) ZE%() '+) K%"L) 2083'E"8%(3) %++%53#) K%$%) G6#%$E%&) +G$) 31%) '(1'6'3'G() G+) 5"$6G, :&$"#%#) HUCX) +G8&) E"8%(5%C5G$$%53%&) '(5$%"#%I,) '2>$GE%&) >G3%(5:) H'() 31%) 2'5$G2G8"$) $"(J%I) "(&) #%8%53'E'3:) K%$%) (G3'5%&) 5G2>"$%&) 3G) 31%)
, $%(%) #5"++G8&#) 0#'(J) 31%) 58'5LC3:>%) 5G>>%$C2%&'"3%&) "M'&%C "8L:(%) 5:58G"&&
,
,
, $G+<)9$<)7<)902:,)9$<)=<)@8$'51,)9$<)B<CD<)F'(02
, 303)&%#)\'G2G8?508%#)/"N)/G0##%$G()HY\//I
, UX`);!e=,)Z!=;/,)@('E%$#'3?)&%)/G(3>%88
, &%)8cZ5G8%)!G$2"8%,)WXUb])/G(3>%88'%$)
,
,
, $6")9%>"$32%(3 h)=%53'G()G+)71"$2"5%03'5"8)"(&) !03$'5%03'5"8)=5'%(5%#,)@('E%$#'3i)&%J8')=30&')&')T'$%(M%)h)^'")@JG)
G,)T8G$%(5%)HY3"8:I =0>>G$3'(J)'(+G$2"3'G()+G$)31'#)"$3'58%)'#), J'E%, issue.3 ,
,
, Chemistry-A European Journal, vol.6
, O) '(1'6'3G$#<-Sa. ) 41%#%)
, K1'51) K%$%) #:(31%#'M%&) 6:) 2083'>8%
, $G2) 7O/O/) &%(&$'2%$#)
, 2>$GE%2%(3) G+) 31%) '(1'6'3G$:) >$G>%$3'%#) "J"'(#3) 31%) &'++%$%
, #G+G$2#) 3%#3%&) 5G2>"$%&) 3G) 31%)
8%(3) '(1'6'3G$<) 9%>%(&'(J) G() 31%) '#G+G$2) 5G(#'&%$%& ,
, &%(&$'3'5)%++%53#)HG$)2083'E"8%(3,)G$)J%(%$"3'G() %++%53I-Sb. )K%$%)%E'&%(5%&)K'31)31%#%)#:#3%2#<), K%"L)3G)'2>G$3
, 9%#>'3%) 31%#%) #'J('+'5
0>) 3G) (GK) #3'88) 1"E%) ") 8'2'3%&) #G806'8'3:) '( ,
, G+) 3GN'5) 2%3"8) 5"3"8:#3#) 31"3) "$%) &'++'5083) 3G) $%2GE%,) G$) 51%2'5"8)
53'G(#) 31"3) >$G&05%) 6:C>$G&053#<) 41%$%+G$%,) '3) '#) '2>G$3, p.3 ,
, >>$G"51%#)+G$)>$%>"$, &%E%8G>)(GE%8)#:(31%3'5)
, O) '(1'6'3G$#<) Y() 31'#) KG$L,) K%) %N>8G$%) 31%) 0#%) G+) >%>3'&%C6"#%&)
, #5"++G8&#) "(&) 2%3"8C+$%%) 58'5LC3:>%) 6'G5G(Q0J"3'G(, pp.3-51
#)#5"++G8&#)'#)%N>%53%&)3G)'2>"$3)%(1"(5%&) ,
, (&) GN'2%) 8'J"3'G(#-Ud. ) "#) "() %++%53'E%) "(&) +"5'8%) K":) G+) >$%>"$, 3%$C#G806'8'3:<) F%) #%8%53%&) 1:&$"MG(%)
, #)")L%:)>$%$%R0'#'3%)K1%()5"$$:'(J)G03)2083'>8%)8'
, G(%) >G3) j,) &G) (G3) $%R0'$%) 2%3"8) 5"3"8:#3#) 3G) G>%$"3%, vol.8
#) ") #'&%C>$G&053<) F%) #1GK) 31"3) 31'#) #:(31%3'5) ,
, O)'(1'6'3G$#<)
88:) 0#%&) &$0J#,) >$'2"$:) #08+G("2'&%#) eC =PU!VU) HK1%$%) e) 2":) 6%) "8'>1"3'5) G$) "$, p.58 ,
, G+)31%)2G#3)'2>G$3"(3)58"##)G+)'(1'6'3G$#)"53, 5G(#3'303%)G(%)
, 1:&$"#%#<) ) 41'#) 2G&%8) G+, 31%) 2%3"88G%(M:2%#) 5"$6G('5)
%)#%8%53%&)+G$)31'#)#30&:<-S[. )P()31%)G31%$)1 ,
, K%) #%8%53%&) 5:58'5)
, 8&%1:&%) J$G0>#, #) 2083'E"8%(3) #5"++G8&#<) F1'8%) 31%) 8'(%"$) >%>3'&%) #5"++G8&) '#) 2G#3)
68:)0(#3$0530$%&)"(&)R0'3%)+8%N'68%,)'3#)5:58'5)5G0(3%$ ,
M%&) j) &0%) 3G) ?C#1%%3C3:>%) '(3%$"53'G(#) j) K'31) ,
, 8&%1:&%) J$G0>#) >G'(3'(J) 3GK"$&#) 31%) #"2%) &'$%53'G(<-UU. ) 41%#%) #5"++G8&#) 1"E%) "8$%"&:) 6%%()0#%&)+G$)>$%>"$'(J,)31$G0J1)2083'>8%)GN'2%), +G0$) 51"'(#) 6%"$'(J) 31%) $%"53'E%)
) 3:>%#) G+) >%>3' ,
R0%G0#)#G806'8'3:)"(&)JGG&)#3"6'8'3:)&'(!&)#*) ,
,
J%&) 31%) #:(31%#'#) G+) #08+G("2'&%) '(1'6'3G$#) ,
, 6%"$'(J) "2'(GGN:) "(&) 1:&$"M'&%) +0
, 31$G0J1,) $%#>%53'E%8:,) GN'2%) "(&) 1:&$"MG(%)
, #<) \G31) G+) 31%2) "$%) %++'5'%(3) 58'5L) 2%31G&#) "88GK, p.31
, ) 3G) G>%$"3%) 51%2G#%8%53'E%8:) '() 2'8&) 5G(&'3'G(#) "(& 1'J1) :'%8&#,) K1'51) 2"L%) 31%2) "() %N5%88%(3) 3GG8) +G$) 31%)
, G+)2083'E"8%
31$%%) #3%>#) H=51%2%) SI<) T'$#3,) WC518G$GC >$G>"(%#08+G(:8) K"#) $%"53%&) K'31 ,
, G+)31%)518G$'(%) 6:) +C1:&$GN:>131"8'2'&%) 31%() +0$('#1%&) 5G2>G0(&) D) '() ]Uk) :'%8&<) 41%) +'("8) &%>$G3%53'G() K'31) 1:&$"M'(%) >$GE'&%#) 31%) +', '&%)C<-U[. )41%)(058%G>1'8'5)#06#3'303'G(
2'5) "5'&) H=51%2%) SI<) 41%) #08+G("2'&%) J$G0>) K"#) '(#3"88%&)6:)31%)#06#%R0%(3)$%"53'G()K'31)518G$G#08+G, 3KG) #3%>#) #3"$3'(J) +$G2) 1:&$G5'(, vol.88, p.6 ,
, 3%&)K'31)E"$'G0#)#5"++G8&#)6%"$'(J)
C>)=:(31%#'#)G+) ,
, O)'(1'6'3G$#)6%"$'(J)"2'(GGN:)"(&)1:&$"M'&%)J$G0>#)
, +G$) +0$31%$) 5G(Q0J"3'G(, vol.6
, , p.9
, Ukh) '''I) !VU!VU,) /%PV,) aWkh) 'EI) SI) V=PW;8,) UI) !VXPV,) WI) VU=PX
,
, 31%#%) #:(31G(#,) K%) +'$#3) >$%>"$%&) 2G(GE"8%(3) 5G(Q0J"3%#)
, CI)H=51%2%)UI)31"3)K'88)#%$E%)"#)$%+%$%(5%)+G$)'&%(3'+:'(J) 2083'E"8%(3) %++%53#<) 410#,) K%) 5G(
8&%1:&%)31"3)2'2'5)31%)#3$0530$%), J8:GN:8'5), p.31 ,
#%&) 2083'E"8%(3) #:#3%2#<) ,
, G2>G0(&) J,) 31%)
, 53'E"3%&)%#3%$)G+)>$G3%53%&), C#%$'(%
, C603:8"2'(%)3G)2"L%)5G2>G0(&)K,)"(&)31%)>$G3%53, J)J$G0>#
, $%2GE%&) '(
3'E%)L<)41%)GN'&"3'E%)58%"E"J%)G+)31%)"2'(G)"85G1G8,) "(&) 31%) 8'J"3'G() $%"53'G() K%$%) 31%() #06#%R0%(38:) 5"$$'%&) G03) '() G(%)>G3)3G), ++G$&) ,
, &) 31%) GN'2%) 8'J"3'G() K%$%) 5"$$'%&) G03) '() "5'&'5) 2%&'",) $%#>%53'E%8:) '() ") >V) [<d) 60++%$
D>) =:(31%#'#) G+) 2G(GE"8%(3) #08>1G("2'&%C3:>%) ,
(1'6'3G$#<) 'I) 'C 603:8"2 ,
, aXkh) ''I) 4TOl4Y=lVUP,) b]kh) '''I)
5%3"3%) 60++%$) HSdd) 2/,) >V) [<dIh) 'EI) 1:&$"M'&%) E,) #G&'02) "5%3"3%) 60++%$) HSdd) 2/,) >V) [<dI,) U`k) +G$) 3KG) #3%>#h) EI) !"YPX,) VUPl4TO) ,
2'(GGN:)B,)VUPl4TO)bb<bld<S,)SUk)+G$)3KG)#3%>#<) ,
, 3G) >$%>"$'(J) 2083'E"8%(3) #:#3%2#) +$G2) 31%)
, 8'M%&) >%>3'&%) #5"++G8&#) CC) "(&) CD<) F1'8%) 31%) 8, +0(53'G
, >%>3'&%) #5"++G8&) CD) '#) 2G#3) >$G6"68:) 0(#3$0530$%&) "(&) R0'3%)
3)1"#)6%%()58%"$8:)&%2G(#3$"3%&)31"3)31%)5:58'5)>%>3'&%) ,
M%&) '() 31%) #G8'&C#3"3%) "(&) '() #G803'G()j) 31%) +G0$) "$2#) >G'(3'(J) 3GK"$&#) 31%) #"2%) &'$, #5"++G8&) CC) '#) 1'J18:) ,
, 03G2"3%&)#G8'&C>1"#%), vol.6
, #), >%>3'&%) #:(31%#'#) H=77=I) G() ") UC518G$G3$'3:8) 518G$'&%) $%#'
, &%#5$'6%&<-U`. ) 41%) #:(31%#'#) G+) 31%) 5:58'5) >%>3'&%) '(EG8E%#) '(C#G803'G(
, +G88GK%&)6:)"()GN'&"3'E%)58%"E"J%)G+)#%$'(%)#'&%C51
, 8&%1:&%) J$G0>#<) 41%) #:(31%#'#) G+) 31%), 3G) 0(2"#L) 31%) J8:GN:8'5)
, 5%3:8"3'G() G+) 31%) !C3%$2'("8,) 58%"E"J%) "(&) &%>$G3%53'G(,) "(&) GN'&"3'E%) 58%"E"J%) G+) #%$'(%) #'&%C51"'(#<) F%) 31%() >$%>"$%&) 3KG) #%$'%#) G+), $) >%>3'&%) '(EG8E%#)
, O) '(1'6'3G$#f) 31%)
$%&) 6:) GN'2%) 8'J"3'G(, +$G2) %(M:2%) '(1'6'3G$) B) ,
&)31%)#%5G(&)G(%)>$%>, $%&), vol.6 ,
, E) H=51%2%) XI<) 41%) GN'2%) 8'J"3'G() K"#) 3:>'5"88:) 5"$$'%&) G03) '() "5'&'5) 2%&'02) HVUPl4TO) bb<bld<SI) "(&) 31%) "5:81:&$"MG(%) 8'J"3'G() K"#) >%$+G$2%&) '(, +$G2) %(M:2%) '(1'6'3G$)
, 3) >V) [<d<) 41%) 3%3$"E"8%(3) 5G(Q0J"3%#) K%$%) '#G8"3%&) 6:) #%2'C>$%>"$"3'E%) $%E%$#%C>1"#%) V7m;) '() WdC
&)3G)'(&'E'&0"8)$%"53'G():'%8&#)G+)`XCbWk<) ) ,
,
, O)'(1'6'3G$#)CB)"(&)CF)6:)GN'2%)8'
M%&) "(&) +8%N'68%) +0(53'G("8'M%&) >%>3'&%) #5"++G8&#,) $%#>%53'E%8:) CC)"(&)CD<)m'J"3'G( ,
, ##":#) K%$%) 0#%&) 3G) 5G2>"$%) 31%), !&)#*) %(M:2%) '(1'6'3'G(
, G+) 31%) 2G(GE, vol.8, p.3
, #G+G$2#) j) 31%) 5:3G#G8'5) 1
(&) YY) j) "#) K%88) "#) 31%) 3$ ,
&) _YY<) T'$#3) G+) "88,) K%) G6#%$E%&) 31"() (G) '(1'6'3'G() '#) G6#%$E%&) K'31) 31%) >%>3'&%) #5"++G8&#) CC ,
, 68%)SI<)Y()31%)GN'2%)#%$'%#,)K%)G6#%$E%&)31"3)31%)
, 3%) CI) '#), p.3
, O) '(1'6'3G$) &'#>8":'(J) ") 2"$L%&)
, , vol.3, p.1
(&) CJ) 6:) 1:&$"MG(%) 8'J"3'G(, O) '(1'6'3G$#) CE) ,
E%8:) CC) "(&) CD<) m'J"3'G() $%"53'G(#) 5"$$'%&) G03) '(, 5%3"3%) 60++%$) HSdd) ,
, >V)[<dI<( P()31%)G31%$)1"(&,)31%)5G$$%#>G(&'(J)2083'E"8%(3)5G(Q0J"3%#)CB) "(&) CF) "$%) 2051) 8%##), vol.3
, O) Y_) H"#) K%88) "#)
, O) ^YY) "(&), p.1
,
8%(3) CI) '#) G6#%$E%&) G( ,
(&) Y^) H4"68%) SI<) Y() 31'#) 5"#%,) 31%) $%8"3'E%) >G3%(5:) H$>I) '(5$, #%#) SWC) ,
E%8:<)) ) ,
, C>)e%#083#)G+)31%
, ##":)+G$)31%)>%>3'&%)#5"++G8&#)CC)"(&)CD,)
8%(3)GN'2%)CI,) ,
, TG$)31%)'(1'6'3'G()G+)1
>G#'3'E%)2083'E"8%(3)%++%53)5G08&)6%) ,
, 5%) 31%) $%8"3'E%) >G3%(5:) >%$) #08+G("2'&%) '(1'6'3G$)
#%#) 6:) ") +"53G$) G+) W<W) 5G2>"$'(J) 3G) 31%) ,
, 8%(3) 5G2>G0(&) 31"3) 5G(3"'(#) 31%) %N"53)
, 8%(3) 5G(Q0J"3%) 60'83) +$G2) 31%) 8'(%"$) >%>3'&%) #5"++G8&), 41%) 2083'E"
, H5G2>G0(&) CF,) 4"68%) SI) 30$(#) G03) 3G) 6%) 8%##) >G3%(3) G(
, #G+G$2#) 31"() 31%) 2083'E"8%(3) 5G(Q0J"3%) 60'83) +$G2) 31%) 5:58'5) >%>3'&%)
31%) 1:&$"MG(%) #%$'%#,) K%) +G0(&) 31"3) 31%) 2G(GE"8%(3) 5G(Q0J"3%)H)'#)")E%$:)JGG&), p.1 ,
, 31)")JGG&)#%8%53'E'3:)"2G(J)31%)'#G+G$2#)3%#3%&<)
G6#%$E%&)K'31)5G(Q0J"3%)CE)G( ,
&) _YY) H$>l() o) S,) 4"68%) SI< ,
, &%) G+) 31%) 5:58'5) #5"++G8&) H5G2>G0(&) CEI) #1GK#) "() '2>$GE%&) >G3%(5:) K1%(
, 31%)8'(%"$)#5"++G8&)H5G2>G0(&)CJ,)4"68%)UI<)
, D>) e%#083#) G+) 31%
, ##":) +G$) 31%) 2G(GE"8%(3) 5G2>G0(&) H,) "(&) 31%) 5G$$%#>G(&'(J) 2083'E"8%(3) 5G(Q0J"3%#) CE) "(&) CJ,) '() 31%) 1:&$"MG(%) #%$'%#<
,
,
, O)^YY)), p.1
,
,
>>$G"51) 31"3) %("68%#) 31%) ,
, G+) 2083'E"8%
, O) '(1'6'3G$#) +$G2)
, +0(53'G("8'M%&) >%>3'&%) #5"++G8&#<) 41%) %(M:2%) '(1'6'3'G(
8%&)31"3)2083'E"8%(3)%++%53#)G550$)#>%5'+'5"88:)K'31)")5G0>8%) ,
, G+
, #G+G$2#,)"(&)2G$%)#>%5'+'5, vol.88, p.1
, O)YY<)41'#), vol.1, issue.G2%
, 6%) &0%) 3G) 31%) %N'#3%(5%) G+) ") #%5G(&"$:) 6'(&'(J) #'3%
G0#8:) #0JJ%#3%&,) G$) 6:) 31%) "6'8'3:) G+) 5%$3 ,
68:)G(3G)31%)2083'E"8%(3)#:#3%2<)F%)"8#G)G6#%$E%&) ,
, 8) &'++%$%(5%#,) 31%) ("30$%) G+) 31%) #5"++G8&) j) 5:58'5) E%$#0#)
, $) j) 1"E'(J) ") #0$>$'#'(J) %++%53) G() 31%) >G3%(5:) G+) 31%#%)
, O) '(1'6'3G$#<) 41%) +"53) 31"3) >$%CG$J"('M%&) 5G(Q0J"3%#) CB)
, #1GK)"()%(1"(5%&)>G3%(5:)5G2>"$%&)3G)5G(Q0J"3%#)CF)"(&)CJ)
, 3G) '(&'5"3%) 31"3) 31%) #3$0530$"8) +'3) 6%3K%%(
, &) 31%, O#)
, 2>G$3"(3) $G8%<) 410#,) '3) '#) >G##'68%) 31"3) #3"3'#3'5"8) %++%53#) "$%) "3) 31%) G$'J'() G+) 31%)
&) G>%$"3%) 31$G0J1) "() '(5$%"#%) '() 31%) 8G5"8 ,
, G+
, &&'3'G() 3G) #3$0530$"8) &"3") "6G03) >G##'68%) #'3%#) +G$) #%5G(&"$:) '(3%$"53'G(#,-SU. ) 31'#) E%$#"3'8%) 2%31G&G8GJ:) #1G08&)
, E%)#3$0530$%C"53'E'3:)$%8"3'G(#1'>#)'()31'#), $%")G+
, &) #G8E%(3#) K%$%) G+) 5G22%$5'"8
5"3'G(<) 4m;) "("8:#%#) K%$%) >%$+G$2%&) G() #'8'5") J%8) ]d) ,
, $)6:) ('(1:&$'() #3"'('(J<) /%83'(J) >G'(3#) K%$%) &%3%$2'(%&) G() ") \q51') /%83'(J) 7G'(3) [Sd<) S V) "(&) SW ;) !/e) #>%53$") K%$%) $%5G$&%&) G() \$05L%$) OE"(5%) Xdd)'(#3$02%(3#)"(&)K%$%)$%+%$%(5%&)K'31)$%#>%53)3G)31%)$%#'&0"8)#G8E%(3) >%"L<)9"3")"$%)$%>G$3%&, #)+G88GK#f)51%2'5"8)#1'+3)Hr)'()>>2I,)2083'>8'5'3:) H#)+G$)#'(J8%3,)&)+G$)&G068%3,)3)+G$)3$'>8%3,)2)+G$)2083'>8%3,)&&)+G$)&G068%3)G+)
, $) G+) 6$G"&I,) 5G0>8'(J) 5G(#3"(3) H.) '() V%$3MI), &G068%3
, #%&) +$G2) /%$5L<) V7m;) "("8:#%#) K%$%) >%$+G$2%&) G() ") F"3%$#) V7m
, U]b[)HZ;)!058%G#'8)WddC[)
, HSU[)t)W)22I)5G802(,)/"51%$%:C !"J%8I) %R0'>>%&) K'31) ") F"3%$#) bb]) 9O9) &%3%53G$<) 41%) +G88GK'(J) 8'(%"$)
, ) G+) #G8E%(3) \) H"5%3G('3$'8%I) '(3G) #G8E%(3) O) HSdd) 2/)
22G('02) "5%3"3%l"5%3G('3$'8%) b[l[I) K%$%) 0#%&f) d) 3G) b[k) G+) ,
, G() 3'2%#) H3eI) "$%) J'E%() '() 2'(03%#<) =%2'C >$%>"$"3'E%) e7CV7m;) K"#) >%$+G$2%&) G() ") F"3%$#), #G8E%(3) \) '() X[) 2'(<), p.3
, , vol.4
J%8I) %R0'>>%&) K'31) ") F"3%$#)UXà) &%3%53G$<) /%31G&) Of) 8'(%"$) J$"&'%(3) G+) "5%3G('3$'8%)'(3G)HSdd)2/)3$'%31:8"22G, s2,) HU[d) t) USI) 5G802(,) /"51%$%:C!" ,
, 5%3G('3$'8%l4TO) bb<bld<S) '(3G) VUPf) dk) 3G) Xdk) '() X[) 2'(<) /Om9YC4PT) "(&)1'J1)$%#G803'G()2"##)#>%53$G2%3$:)"("8:#%#)K%$%)5"$$'%&)G03)G()"() @83$"+8%N)YYY), 3G) Xdk) '() X[) 2'(<) /%31G&) \f) 31%) +G88GK'(J) 8'(%"$) J$"&'%(3) G+)
,
&&%&) 3G) ") #G803'G() G+) WC518G$GC>$G>"(%) #08+G(:8) 518G$'&%) Hd<SX) 2mh) S<S) 22G8h) S) %R0'E<I) '() 9;/) HS<U) 2mI<) O+3%$) #3'$$'(J) W) 1G0$#,) 31%), +0/9&7#( RCS<) S<U) 2m) G+) "22G('02) 1:&$GN'&%) #G803'G( ,
#) 3$'30$"3%&) '( ,
, &) 31%) >$%5'>'3"3%) K"#) +'83%$%&)
, #1%&)K'31)9
, /<)41%)+'83$"3%)K"#)31%(, vol.5
8<) D'%8&f) b[) kh) S V) !/e) HXdd) /VM,) ;9;8WI) ? ,
W<`d) H3,) .( n) ]<U) VM,) UV,) ,
, <U) VM
`) j) U<U]) H2,) UV,) ;VUC;VUC;VUIh) SW ;) !/e) HSdS) /VM,) ;9;8WI)r) ,
XU<][)H;8C;VUI,)U`<d`)H;VUC;VUC ,
, BQRRCTBQ7&+O+&*+&07+.&0QDQ6.S+O6S:4+:/0#QCQ*-."+0/9&7#( RDS<) 4G) ")
G+)5G2>G0(&)C)Hd<W)Jh)S<b)22G8h)S)%R0'E<I)'()9/T)HU)2mI)K%$%, &&%&) #055%##'E%8:) +C1:&$GN:>13"8'2'&%) Hd<UU) Jh) U<U) 22G8h) S<U) %R0'E<I ,
, G&'&%) Hd<a[) Jh) U<U) 22G8h) S<U) %R0'E<I)
, %31:8"2'(%)Hd<Sa)2mh)d<UU)22G8h)S<U)%R0'E<I<)O+3%$)$%+80N'(J)GE%$, vol.13
&) 31%) >$%5'>'3"3%) K"#1%&) K'31) O5PZ3<) 41%) 2'N30$%)K"#)31%()K"#1%&)3K'5%)K'31)")#"30$"3%&)#G803'G()G+ ,
('5) 8":%$) K"#) &$'%&) GE%$) "(1:&$G0#) #G&'02) #08+, vol.3 ,
(&) 5G(5%(3$"3%&) 0(&%$) E"5002<) 41%) $%#083'(J) >GK&%$) K"#) $%C ,
88'M%&) +$G2) %31"(G8) 3G) J'E%) ") K1'3%) #G8'&<) D'%8&f) ]U) kh) 2>f) SaSv;h) ,
, VeCZ=YC/=)-/wV. w ) 5"8508, 3%&) +G$)
,
VM,)9/=PC1]I)?)`<a])H#,)XV,) ,
,
, <X) VM,) UV,) PC
, W<UU) j) W<Sb) H2,) UV,)
U<SX) j) U<dW) H2,) UV,) ;VUC;VUC ,
,
,
,
,
,
,
,
, +0/9&7#( RBS<) /%31:81:&$"M'(%) HW]) xmh) d<`)
&&%&) 3G) ") #G803'G() G+) 5G2>G0(&) D) Hd<S) Jh) d<W ,
Z3PV)HS)2mI<)O+3%$)#3'$$'(J)"3)$GG2)3%2>%$"30$%)+G$)X) ,
31%)2'N30$%)K"#)5G(5%(3$"3%&)0(&%$)E"5002)"(&)31%)$%#'&0%)K"#) ,
#'8'5") J%8) 0#'(J) O5PZ3lZ3PV) HblSI) "#) %80%(3<) 41%) %N>%53%&) ,
, #) ") 5G8G0$8%##) G'8<) D'%8&f) aW) kh) S V) !/e) HXdd), 5G2>G0(&) K"#) G63"'(%&)
=PC1]I)?)]<`a)H#,)UV,)=PU!VUI,)]<dd)H6$,)UV,)PC!VUI ,
,
, W<dS)j)U<bW)H2,)UV,)
S<b`)j)S<a[)H2,) ,
, UV,) ;VUC;VUC;VUIh) SW
,
UU<ba) H;VUC;VUC;VUIh) VeCZ=YC/=)-/wV. w ) 5"8508, 3%&)+G$) ,
Sb<b)22G8h)S)%R0'E<I)K"#)#8GK8:)"&&%&)3G)518G$G#08+G ,
, SSb<X)22G8h)])%R0'E<I)"3)dv
53'G()2'N30$%)K"#)#3'$$%&)"3)dv;)H'5%) ,
&)31%()K"$2%&)3G)$GG2)3%2>%$"30$%)"(&)#3'$$%&)+G$)W ,
, &) 31%) #G8'&) K"#) K"#1%&) K'31) 5G8&, 1G0$#<) 41%) #0#>%(#'G() K"#) +'83%$%&)
, &&%&)3G)")#G803'G()G+) "22G('02)1:&$GN'&%)HW)2m,)U[k)'()K"3%$I)
&&'3'G()G+)U)2m)G+)K"3%$,)31%)2'N30$%)K"#)"5'&'+'%&)3G)>V)UCW)K'31 ,
R0%G0#) #G803'G() G+) V ,
, 8<) O+3%$) 5G
, G+)S<a)2m)#08+0$'5) "5'&)'()Xd)2m)G+)2%31"(G8<)41%)#G8E%(3)K"#)31%(, G63"'(%&):%88GK)#G8'&)K"#)$%+80N%&)W)1G0$#)'()")#G803'G(
(&) 31%) $%#'&0%) G63"'(%&) K"#) 3$'30$"3%&) K'31) Z3UP) 3G ,
3%,) K1'51) K"#) +'83%$%&,) K"#1%&) K'31) Z3UP) ,
, n)a<X)VM,)UV,)
, <XS)H&,).(n)a<X)VM,)UV,)
,
,
, U<bS)H3,).)n)`<[)VM,)UV,);VUC;VUC;nPI,)U<]`)H3,).)n)
, <[) VM,) UV,) ;VUC;VUC;nPIh) SW
SXU<Sb) H;"$C;VUI,) SUa<`b) H ,
,
,
,
, VeCZ=YC/=)-/wV. w ) 5"8508"3%&) +G$)
, 4+:6.S3#0U#0#*-."+0/9&7#( RES<) O) #G803'G(
, 5G2>G0(&) F) Hd<]) Jh) U<]) 22G8h) S) %R0'E<I) ) '() 2%31"(G8) HU`) 2mI) K"#)
, 1G0$#)K'31)1:&$"M'(%)2G(G1:&$"3%)HS<U)2mh)U]<U)22G8,)Sd)
, 31%) $%"53'G() 2'N30$%) K"#) 5GG8%&) "3) dv;) +G$) Wd) 2'(, pp.0-3
3%<)41%)8"33%$)K"#)+'83%$%&,)K"#1%&)K'31)2%31"(G8) "(&)&$'%&)'()!/0%*<)41%)#G8'&)K"#)$%C5$'#3"88'M%&)+$G2)%31 ,
, #) ") K1'3%) #G8'&<) D'%8&f), p.2
, VM,) 9/=PC1]I) ?) b<dS) H#,) SV,) !VC!VUI,) `<`[) H&,) .) n) a<X) VM
, <W`)H&,).(n)a<X)VM,)UV,)
, <Ub)H#,)UV,)=PU!VUI,)X<Sa)H6$,)UV,)
U<aa)H3,).(n)`<])VM,)UV,);VUC;VUC;nPI,)U<W[)H3,).)n)`<])VM ,
,
,
,
X) H;VUC;VUC;nPI<) VeCZ=YC/=)-/wV. w ) 5"8508"3%&) ,
, +G0(&)UXX<d`]d<( RD"SQ#Q3-%6.QDQRV$%&$Q3-%+O6$/43+06.W/9&0+SQBQR$%&$Q3-%+O6S( :4+:/0/9&7#( RKS<) Y() ") #G803'G() G+) \G5C=%$HP)60IC#055'
, S)%R0'E<I)'(
&&%&)'C603:8"2'(%)Hd<W])2mh)W<]) ,
8%31:8"2'(%) HS<b) 2mh) SS) 22G8h) X) ,
3) $GG2) 3%2>%$"30$%) GE%$('J13,) 31%) 2'N30$%) K"#) ,
, #1%&)#055%##'E%8:)K'31)S!)"R0%G0#)#G803'G()G+)V;8,)#"30
&) 6$'(%<) 41%) G$J"('5) 8":%$) K"#) &$'%&) GE%$ ,
, &) +'83%$%&<) 41%) +'83$"3%, #G&'02) #08>1"3%)
, 5002)3G)J%3)5G2>G0(&)K)"#)")K1'3%)#G8'&<)D'%8&f)aX)kh)2>f
, VM,);9;8WI)?)]<[[)H6$,)SV,)
<XW)H6$,)SV,) ,
,
) j) W<`S) H2,) SV,) ;VC;VUI,) W<WX) H#,) SV,) ;VC ,
, H&&,) .( n) SU<a
,
S<S`)H#,)bV,)PC)\0I,)d<bS)H3,).(n) `<W)VM,)WV,);VUC;VWI<) SW ;)!/e)HSdS)/VM,);9 ,
<[a)HH;nPIPC)\0I,)`W<bU)H;H ,
, U<dd)H;VC;VUI,)Wb<Ud)H
,
, Wa<`d) H
,
X) H;VUC;VWI<) VeCZ=YC/=)-/wV. w ) 5"8508, 3%&) +G$) ,
,
,
, G2>G0(&) K) Hd<]b) Jh)U<U)22G8h)S)%R0'E<I)K"#)"&&%&)3G)Ua)2m)G+)")#G803'G()G+)4TOl4Y=lVUP)
3)$GG2)3%2>%$"30$%<)41%)2'N30$%)K"#) 31%() 5G(5%(3$"3%&) 0(&%$) E"5002) "(&) 31%) $%#'&0%) K"#) 3$'30$"3%&) K'31) Z3UP<)41%)$%#083'(J)>$%5'>'3"3%)K"#)+'83%$%&) ,
, #)")K1'3%)#G8'&<)D'%8&f)b])kh)2>f)bbv;h) S V
I)?)a<W])H3,).)n)[<X)VM,)SV,) ,
, a<SS)H#,)UV
,
VUCPVI,)W<ad)j)W<]d)H2,)WV,);VC;VUI,)W<SS)H&&,) ,
,
H2,)UV,);VUC;VUC;VUI,)S<WS)j)S<UU)H2,)UV,) ;VUC;VWI,)d<à) H3,( .) n) `<W) VM,) WV,) ;VUC;VWIh) SW ,
,
U)H;VUC;VWIh)VeCZ=YC /=)-/wV. w )5"8508"3%&)+G$)-;`VS`!UPU ,
, Hd<S) Jh) d<]) 22G8,) S) %R0'E<I) K"#) &'##G8E%&) '() ]d) 2m) G+) "R0%G0#) 60++%$) HSdd) 2/) #G&'02) "5%3"3%,) >V), G2>G0(&) L)
&&%&<)41%)$%#083'(J)2'N30$%)K"#)#3'$$%&)W) ,
3)$GG2)3%2>%$"30$%,)"(&)31%()R0%(51%&)K'31), U=UPW)Hd<S)Jh)d< ,
&&%&) "(&) 31%) #G803'G() K"#) #3'$$%&) GE%$('J13) "3) $GG2) 3%2>%$"30$%<) 41%) 2'N30$%) K"#) %N3$"53%&) 3K'5%) K'31) O5PZ3) ,
, #1%&)K'31)6$'(%,)31%()&$'%&)GE%$)"(1:&$G0#)#G&'02)#08+"3%)
, 3%)K"#)5G(5%(3$"3%&)0(&%$)E"5002)"(&)31%)$%#'&0%)K"#)>0$'+'%&)
#'8'5") J%8) 0#'(J) O5PZ3l;:58G1%N"(%) HalUI) "#) %80%(3<) 41%) %N>%53%&) ,
, #)")K1'3%)#G8'&<)D'%8&f)U`)kh)2>f)SSbv;h) S V), 5G2>G0(&)H)K"#)G63"'(%&)
, VM,)9/=PC1]I) ?) Sd<[) H6$,) SV,)
, Vn!I,) a<Ud) H3,).) n) ) [<b) VM,)
<`U)H&,).)n)a<W)VM,)UV,) ,
, <XW)H&&,).)n)SW<`,)a<U)
,
, <U[)H#,)UV,)=PU!VUI,)W<SW)H&&,).)n)SW<W,)]<a)VM,)UV,)
W<dX)jU<à)H2,)XV,);VUC;VUC;nPI,)S<Xb)j)S<W[)H2,)UV,);VUC;VUC ,
<W)VM,)UV,);VUC;VWI,d<à)H3,) .)n)`<W)VM,)WV,) ;VUC;VWIh) r) SW ;) !/e) HSdS) /VM,) 9/=PC1]I) ?) S`W<bb) H!C!VC, vol.nPI ,
,
,
, Vn!I,)SUa<bU)H
,
,
WU<ad)H;VUC;VUC ;nPI,) WS<U]) H;VUC;VUC;VUI,) Ub<X]) H;VUC;VUC;nPI,) Sb<]a) H;VUC ,
, SW<]a) H;VUC;VWIh) VeCZ=YC/=)-/wV. w ) 5"8508, 3%&) +G$)
,
, /9+6.:4+:+O6S&9&0+S/$#%/9&7#
$%&)+G88GK'(J)31%)#"2%)>$G5%&0$%)"#)+G$)5G2>G0(&)H)603)0#'(J) GN:"2'(%)B)Hd<S)Jh)d<][)22G8,)S)%R0'E<I)'( ,
, )41%)%N>%53%&)5G2>G0(&) K"#)G63"'(%&)"#)"):%88GK)G'8<)D'%8&f)
HXdd)/VM,)9/=PC1]I)?)a<U`)H3,).)n)[<`)VM,)SV,)!VI ,
,
X<UU)H3,).)n)]<X)VM,)UV,)PC;VUI,)W<Sa)j) ,
, W<da)H2,)UV,)
W<d`)j)U<bb)H2,)UV,) ,
U<da)j)U<dW)H2,) .) n) SU<U,) ]<[) VM,) UV,) PC;VUC;VUI,) S<Xa) j) S<W]) H2,) UV,) ;VUC;VUC ,
, S<WW) j) S<Sb) H2,) UV,) ;VUC;VWI,)d<à) H3,) .) n) `<W) VM,) WV,) ;VUC;VWIh) SW ;)
, VM,) 9/=PC1]I) ?) S]d<aW) H!VC;nPI,) SXX<W`) H;Vn!I
S<db) H ,
Wa<Sb) H ,
,
d) H;VUC;VWI,) SW<]d) H;VUC;VWIh) VeCZ=YC/=)-/wV. w )5"8508"3%&)+G$)-;bVUd!WPX= ,
, CF<) a) %R0'E<) H>%$) >%>3'&%) #5"++G8&I) G+) "2'(GGN:) 5G2>G0(&) B) K%$%)
, Chemistry-A European Journal
VUPl9/T)HblSI,)G(3G)")S)2/)#G803'G()G+) ,
, ++G8&) CC) G$) CD) '() VUPl4TO) Hbb<bld<SI<) 41%) 2'N30$%) K"#) #3'$$%&)
3) $GG2) 3%2>%$"30$%) 31%() >0$'+'%&) G() #%2'C>$%>, p.7 ,
, 0#'(J)31%)2%31G&)\)H#%%)J%(%$"8)5G(&'3'G(#I)3G)"++G$&)")K1'3%)#G8'&) "+3%$)+$%%M%C&$:'(J<)
CB<)D'%8&f)WS)kh)V7m;f))e)n)b<bS)2'(h)/Om9YC4GT)HyC, vol.5 ,
,
CF<)D'%8&f)`[)kh)V7m;f))e)n)a<UW)2'(h)/Om9YC4GT)HyC, vol.5 ,
,
, CJ<)a)%R0'E<)H>%$)>%>3'&%)#5"++G8&I)G+)1:&$"M'&%)E)K%$%)"&&%&,)+$G2
, VUPl9/T) HblSI,) G(3G) ") S) 2/) #G803'G() G+), /) #3G5L) #G803'G(
, R0%G0#) 60++%$) HSdd) 2/) #G&'02) "5%3"3%,) >V) [<dI<), #5"++G8&) CC( G$) CD) '(
, 3)$GG2)3%2>%$"30$%)"(&)31%()>0$'+'%&), 41%)2'N30$%)K"#)#3'$$%&)GE%$('J13
$"3'E%) e7CV7m;) 0#'(J) 2%31G&) O) H#%%) J%(% ,
, K1'3%)#G8'&)"+3%$)+$%%M%C&$:'(J<)
, Z674/U+0#( $+0<-=/%#( CE<) D'%8&f) W[) kh), p.7
, 2'5)"5'&If)5"8508, 4GT)HyC5:"(GCXC1:&$GN:5'(
, w )USdb<``,)+G0(&)USdb<aS<
, #) 6%%() 0#%&) +G$) "##":'(J) 31%)
, O) 5"3"8:M%&)
, PU) 1:&$"3'G(
, G+) d<U) 2/I) 1"#) 6%%() 0#%&) "#), 71%(G8) $%&) H"3) ")
3)31%)"6#G$6"(5%)2"N'202)G+)[[`)(2,)K'31)Ud)2/)V%>%#)H>V) ,
, #) 60++%$,) "(&) Ud) 2/) !"U=PX) H+G$) 2"'(
J31I,) +G88GK'(J) 31%) '('3'"8) $"3%#) G+) 31%) ,
, OC5"3"8:M%&)
, +G$) ") >%$'G&) G+) SdCSdd) #<) 41%
, PU), vol.5
, G+) 31%) L'(%3'5) >"$"2%3%$#), ##":) #:#3%2) K%$%f) b<U) (/) +G$) 1
, O) Yh) `<a) (/) +G$) 1
, O) YYh) Sd<U) (/) +G$), p.1
(&)SX<S)(/)+G$)1 ,
51)'(1'6'3G$)"3)8%"#3)#'N)3$"5%#)G+)31%)'('3 ,
53'G() 1"E%) 6%%() 0#%&) +G$) &%3%$2'('(J) 31%) '('3 ,
, 8:M%&)$"3%#)K%$%)&%3%$2'(%&)'()31%)#"2%)2"((%$) "(&)#063$"53%&)+$G2)31%)3G3"8)G6#%$E%&)$"3%#<)=3G5L), E%8G5'3:<-Ua. )41%)0(5"3
$%&) '() &'#3'88%&C&%'G('M%&) K"3%$) "(&) &'803'G(#) 0>) 3G) ,
, K%$%)&G(%)31%$%"+3%$)K'31)&'#3'88%&C&%'G('M%&)K"3%$<)Y(1'6'3G$)
, 3%&)3GJ%31%$)+G$)S[)2'()C)U)1)HG$)8G(J%$, vol.506
, 3)$GG2)3%2>%$"30$%)H"3)Xv;)+G$)31%)8G(J%$)'(506"3'G()>%$'G&#) 31"()S[)2'(I)>$'G$)3G)"##":,)'()G$&%$)3G)"88GK)+G$)31%)+G$2, G+)31%)ZCY)
, 5G2>8%N<) 41%) '(1'6'3'G() 5G(#3"(3#) K%$%) G63"'(%&) 6:) (G(C8'(%"$) 8%"#3C
, %#)2%31G&#)0#'(J)7eY=/)W,)"(&)$%>$%#%(3)31%)2%"()+$G2)"3)8%"#3)
,
, F%) 31"(L) 31%) m'J0%) 5G(3$%) 8%) ;"(5%$) H5G2'3?) &%#) 7:$?(?%#C P$'%(3"8%#I)"(&)31%)m"6ZN)
, CdSI)+G$)
, +0(&'(J<)!<*<)31"(L#)31%)T$%(51)/'('#3z$%)&%
, I)Z<)/"1G(,)/<)\"$6G'0,), #6\+47*?)2083'E"8%(5:){)%(M:2%), vol.73
,
, 6I
,
88%:,)/<)F%6%$,)P<)=%'3M,)=<)V%513,)\<)*GL#51 ,
, B<) 9%$(%&&%
DICD,)@;,)SdX`UCSdXbah)5I)/<), J,) ='5">3, vol.3 ,
, |<)/<)F1'3%#'&%#
, CHHL,)<A,)U`, vol.3
P<)e%("0&%3,)e<)eG:,)9 ,
2',) e<) }%88',) O<), B<CD<) F'(02,) =<) @8$'51,) 7<) 902:,)4#53(6&*7*83, vol.73 ,
I) ,
)6I)e<)}%88',)B<CT<)mG(J%E'"8,)7<)902:,)O<)/"$$, vol.73 ,
, G2>"'(,) O<) \G&8%((%$, vol.9
Sh) &I) =<) |<) |G0'(,) 9 ,
, <)4<)=0>0$"(,)
, , vol.9
, <) 4<) =0>0$"(,) |<) 9%) ='2G(%, vol.9
, A@,)WXbCW[b<)-a. ;<) 4<) =0>0$"(,) B<) D<) F'(02,) J%)%#"( K"1&0&', <)4<)=0>0$"(,), vol.8
, <)4<)=0>0$"(,)\<)/"#%$%%8,)9%##3(M:/#73(N"$3
, S<-Sd.) O<)
, T<)O66"3%,)O<)=5GMM"+"E
, <)4<)=0>0$"(,)6&**#53(K"13, vol.3
,
, XXh) 6I) T<) \088%$,)/<)=3%'(%$,)*<)T$%:,)9<)/'$5#G+,)B<)=51%0%$, vol.9
20$31:,) |<) *<) *"0+2"(,) O<) e<) @$6"51,) Y<) |'38'(,) *<) m<) |0&'L#%(,) 9<) \<) F%'6%8,) |<) /<) F1'3%#'&%#, <)4<)=0>0$"(,)9<)!%$',)=9B, vol.9 ,
, <)4<)=0>0$"(,)O<)/%1&',)B<CD<)
/<) =3'3',) O<) ,
, <) O6&"G0',) ^<) \"$, O<) =5GMM"+"E",)D<)|0"$',)B<)D<)F'(02
, <)4<)=0>0$"(,).3(=73
, B<) D<) F'(02
, <) 4<) =0>0$"(,) .3( ?'QL7"(-':&I3( K"13, vol.73
,
, <) 4<) =0>0$"(,) =<) 7<) ^'(5%(3,) .3( ?'QL7"(-':&I3(K"13
, <) O6%88?(CT8G#,) /<) 4
, <) 4<) =0>0$"(,) =<) 7<) ^'(5%(3,) 4#53( 6&*7*83, vol.73
,
=<) /<) P#2"(,) 9<) ^088G,) O<) |088G33G,) B<) D<) F'(02,) }<) O8P312"(,) Z<) ,
, 73,( DICE,) @P,) XdWbC XdX[h)6I)T<), =<)/<)P#2"(,)9<)^088G,)}<)O8P312, vol.9
, <)4<)=0>0$"(,) 4#53(6&*7*83, vol.73
&%,)O<)P0"8',)e<)m"0$ ,
, <CP<)40$$'(,)B<C7<)/"QG$"8, vol.9
, I)e<)}%88',)Z<)\"$3G8"2',)B<)T<)mG(J%E, =<)@8$'51,)9<)\G30$:(,)O<)/"$$",)P<)e%("0&%3,)7<)902:,), vol.9
, UUSdCUUS]h)6I)Z<)\"$3G8"2',)D<)\%##'(,)!<), =<)@8$'51,)CB9(=1!3
, \%33"51%,) /<) |"$:C\G6G,) /<) |"$5'",) 7<) 902:,) =<) @8$'51,) 4#53( 6&*7*83, vol.73
,
I)=<)7%80#G,)4<)e05L8%,) ,
,
E,) XWUCXW`h) 6I) 7<) 902:,) Y<) /<) ZJJ8%#3G(,) |<), vol.9 ,
,
, B<) |"$5'",) 7<) 902:,) P<) e%("0&%3, vol.9
, I) 9<) \G30$:(,) Z<) 9%+$"(5R,) |<) 4<) 9G8>1'(,) B<) |"$5'",) 7<) m"66%,) P<) e%("0&%3,)7<)902:,).3(M"R)
UUXCUXdh)6I)D<)='(J1,)|<) ,
, 4<)9G8>1'(,)B<)e"ML'(,)7<)902:,)9:"76&*9
4<)/"3#0',)=<)*"2"3",)V<)*"L0#1',)*<)@51'&, vol.9 ,
, =<)TG'88"$&,)/<)P<)e"#20##%(,)B<)e"ML'(,)9<)\G30$:(,)7<)902:,).3(4#53, vol.73
, D<)\%##'(,)^<)|%$E"'#,)7<)902:,)=<)@8$'51,)='5">3, vol.9
, Chemistry-A European Journal This article is protected by copyright. All rights reserved
, G+) 2083'E"8%(5:) '() %(M:2%) '(1'6'3'G() 1"#) 6%%() $%5%(38:) %N%2>8'+'%&) 6:) ") +%K) #%$%(&'>'3G0#)
%#<) F%) $%>G$3) 1%$%) ,
,
, 68%#)31%)%++%53'E%)5G(#3$053'G() G+) 2083'E"8%(3) >%>3'&%C6"#%&) #:#3%2#)
, ##":#) #1GK), +G$) 31%) '(1'6'3'G() G+) 5"$6G('5) "(1:&$"#%#<) 41%) %(M:2%) '(
) K'31) 31%#%) (GE%8) 5G2>G0(&#<) ,
,
, European Journal Keywords: silsesquioxane ? multivalent platform ? oxyamine ? hydrazone ? ligations, Chemistry-A
, New J. Chem, vol.25, pp.1-1, 2001.
, Chem. Asian J, vol.11, pp.2081-2173, 2010.
, Org. Biomol. Chem, issue.11, pp.2224-2236, 2013.
, ACS Appl. Mater. Interf, vol.9, pp.12812-12822, 2017.
, J. Am. Chem. Soc, vol.5, pp.17649-17651, 2010.
, , 2015.
, , vol.46, pp.8797-8808, 2017.
, Eur. J. Inorg. Chem, vol.19, pp.143-150, 2012.
, Fundam. Appl. Toxicol, vol.21, pp.66-70, 1993.
, Angew. Chem. Int. Ed, vol.55, pp.996-998, 2005.
, Angew. Chem. Int. Ed, vol.54, pp.4289-4294, 2015.
, Dalton Trans, vol.45, pp.6124-6138, 2010.
, Org. Biomol. Chem, vol.13, pp.10590-10599, 2015.
, Angew. Chem. Int. Ed, vol.51, pp.2755-2794, 1998.
, Org. Biomol. Chem, vol.23, pp.10306-10309, 2015.
, J. Appl. Polym. Sci, vol.103, pp.2608-2614, 2007.
, Chem. Eur. J, vol.20, pp.15966-15974, 2014.
, Org. Biomol. Chem, vol.8, pp.2212-2218, 2010.
, Org. Biomol. Chem, vol.10, pp.5544-5548, 2010.
, Chem. Eur. J, vol.16, pp.3833-3841, 2010.
, Chem. Eur. J, vol.20, pp.34-41, 2014.
, Org. Biomol. Chem, vol.10, pp.6287-6293, 2012.
, J. Chem. Soc, pp.1491-1497, 1999.
, , vol.44, pp.916-919, 2015.
, J. Chem. Soc, pp.1123-1127, 2001.
, Bioconjugate Chem, vol.24, pp.735-765, 2013.
, Angew. Chem. Int. Ed, vol.13, pp.10183-10187, 2015.